Illumina (ILMN) Net Margin (2009 - 2026)
Illumina's (ILMN) quarterly Net Margin came in at 17.86% in Q2 2026, down 433.0% on a YoY basis from 5.36% in Q2 2025, and up 45.41% quarter-over-quarter from 12.28% in Q1 2026.
Powered by 
Analysis
Illumina (ILMN) Net Margin (2009 - 2026) Analysis & Trends
Illumina (ILMN) has reported Net Margin for 18 consecutive years, with 17.86% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin fell 433.0% year-over-year to 17.86%; the trailing twelve-month figure through Jun 2026 stood at 18.36% (down 1100.0% YoY), and the FY2025 full-year result was 19.57%, up 4755.0% from the prior year.
- Net Margin improved to 17.86% in Q2 2026 per ILMN's latest filing, from 12.28% in the prior quarter.
- Across five years, Net Margin topped out at 65.28% in Q3 2024 and bottomed at 402.07% in Q1 2023.
- Historically, Net Margin has averaged 49.26% across 5 years, with a median of 3.65% in 2022.
- The sharpest annual moves came in 2022 and 2023: Net Margin sank 37085 bps in 2022, then surged 38647 bps in 2023.
- Over 5 years, Net Margin stood at 342.24% in 2022, then surged by 95 bps to 15.6% in 2023, then jumped by 209 bps to 16.94% in 2024, then surged by 70 bps to 28.82% in 2025, then slumped by 38 bps to 17.86% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 17.86%, 12.28%, and 28.82% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 13.89% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 19.28% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 17.86% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 7.10% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 17.01% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 57.05% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 2.45% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -11.87% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -7.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 17.86% |
| Mar 29, 2026 | 12.28% |
| Dec 28, 2025 | 28.82% |
| Sep 28, 2025 | 13.84% |
| Jun 29, 2025 | 22.19% |
| Mar 30, 2025 | 12.58% |
| Dec 29, 2024 | 16.94% |
| Sep 29, 2024 | 65.28% |
| Jun 30, 2024 | -178.78% |
| Mar 31, 2024 | -11.71% |
| Dec 31, 2023 | -15.60% |
| Oct 1, 2023 | -67.38% |
| Jul 2, 2023 | -19.90% |
| Apr 2, 2023 | 0.28% |
| Jan 1, 2023 | -402.07% |
| Oct 2, 2022 | -342.24% |
| Jul 3, 2022 | -46.04% |
| Apr 3, 2022 | 7.03% |
| Oct 3, 2021 | 28.61% |
| Jul 4, 2021 | 16.43% |